Skip to main content

Advertisement

Log in

Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Pleural effusion is an abnormal collection of body fluids that may cause related morbidity or mortality in cirrhotic patients. There are insufficient data to determine the optimal method of drainage, for symptomatic relief in cirrhotic patients with pleural effusion.

Aims

In this study, we compare the mortality outcomes of catheter drainage versus thoracentesis in cirrhotic patients.

Methods

The National Health Insurance Database, derived from the Taiwan National Health Insurance Program, was used to identify cirrhotic patients with pleural effusion requiring drainage between January 1, 2007, and December 31, 2010. In all, 2556 cirrhotic patients with pleural effusion were selected for the study and divided into the two groups (n = 1278/group) after propensity score matching.

Results

The mean age was 61.0 ± 14.3 years, and 68.9% (1761/2556) were men. The overall 30-day mortality was 21.0% (538/2556) and was higher in patients treated with catheter drainage than those treated with thoracentesis (23.5 vs. 18.6%, respectively, P < 0.001 by log-rank test). After Cox proportional hazard regression analysis adjusted by patient sex, age, and comorbid disorders, the risk of 30-day mortality was significantly higher in cirrhotic patients who accepted catheter drainage compared to thoracentesis (hazard ratio 1.30, 95% confidence interval 1.10–1.54, P = 0.003). Old age, hepatic encephalopathy, bleeding esophageal varices, hepatocellular carcinoma, ascites, and pneumonia were associated with higher risks for 30-day mortality.

Conclusion

In cirrhotic patients with pleural effusion requiring drainage, catheter drainage is associated with higher mortality compared to thoracentesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

EVB:

Esophageal variceal bleeding

HCC:

Hepatocellular carcinoma

HE:

Hepatic encephalopathy

HR:

Hazard ratio

NHIB:

National Health Insurance Bureau

NHRI:

National Health Research Institute

RFI:

Renal functional impairment

SBP:

Spontaneous bacterial peritonitis

TIPS:

Transjugular intrahepatic portosystemic shunt

MELD:

Model for End-Stage Liver Disease

References

  1. Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20:271–279.

    Article  CAS  PubMed  Google Scholar 

  2. Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine. 2014;93:135–142.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59:1627–1637.

    Article  PubMed  Google Scholar 

  4. Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Sese E. Usefulness and complications of thoracentesis in cirrhotic patients. Am J Med. 2001;111:67–69.

    Article  CAS  PubMed  Google Scholar 

  5. Norvell JP, Spivey JR. Hepatic hydrothorax. Clin Liver Dis. 2014;18:439–449.

    Article  PubMed  Google Scholar 

  6. Chen TA, Lo GH, Lai KH. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax. JCMA. 2003;66:579–586.

    PubMed  Google Scholar 

  7. Singh A, Bajwa A, Shujaat A. Evidence-based review of the management of hepatic hydrothorax. Respiration. 2013;86:155–173.

    Article  PubMed  Google Scholar 

  8. Alonso JC. Pleural effusion in liver disease. Semin Respir Crit Care Med. 2010;31:698–705.

    Article  PubMed  Google Scholar 

  9. Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int. 2009;3:582–586.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Liu LU, Haddadin HA, Bodian CA, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest. 2004;126:142–148.

    Article  PubMed  Google Scholar 

  11. Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol. 1986;81:566–567.

    CAS  PubMed  Google Scholar 

  12. Mercky P, Sakr L, Heyries L, Lagrange X, Sahel J, Dutau H. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration. 2010;80:348–352.

    Article  PubMed  Google Scholar 

  13. Kilburn JP, Hutchings J, Misselhorn D, Chen AC. Use of indwelling tunneled pleural catheters for the management of hepatic hydrothorax. Chest. 2010;138:418A–418A.

    Article  Google Scholar 

  14. Hung TH, Tsai CC, Hsieh YH, Tsai CC, Tseng CW, Tsai JJ. Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2012;10:677–681.

    Article  PubMed  Google Scholar 

  15. Serste T, Moreno C, Francoz C, et al. The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation. Eur J Gastroenterol Hepatol. 2010;22:207–212.

    Article  PubMed  Google Scholar 

  16. Xiol X, Tremosa G, Castellote J, et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int. 2005;18:672–675.

    Article  PubMed  Google Scholar 

  17. Coral GP, Alves de Mattos A. Renal impairment after spontaneous bacterial peritonitis: incidence and prognosis. Can J Gastroenterol. 2003;17:187–190.

    Article  Google Scholar 

  18. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology (Baltimore, Md). 1994;20:1495–1501.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was based, in part, on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, which is managed by National Health Research Institutes (Registered number: 101516). The interpretations and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health, or National Health Research Institutes.

Author's Contributions

T-HH provided material support, collected and analyzed the data, and drafted the manuscript. C-CT provided material support and contributed to the design of the study. C-WT contributed to the design of the study, provided material support, drafted the manuscript, and critically revised the manuscript for important intellectual content. K-CT provided material support and critically revised the manuscript for important intellectual content. Y-HH contributed to the design of the study and critically revised the manuscript for important intellectual content. C-CT analyzed the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chih-Wei Tseng.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hung, TH., Tseng, CW., Tsai, CC. et al. Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion. Dig Dis Sci 62, 1080–1085 (2017). https://doi.org/10.1007/s10620-017-4463-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4463-8

Keywords

Navigation